IOL Chemicals and Pharmaceuticals Limited (IOLCP) operates within the API and specialty chemicals sectors, offering a diverse range of products for pharmaceuticals and broader industrial applications.

IOLCP has recently secured EDQM certification for Pantoprazole Sodium Sesquihydrate Process-III, bolstering its export capabilities to Europe which points to strengthening its global market reach.

Revenue for H1 FY26 stood at INR 1,119.2 crore, reflecting an 8.9% year-on-year growth, supported by strategic expansions and the ramp-up in non-Ibuprofen APIs.

The company is leveraging backward integration for margins and supply chain resilience, while continuing to expand non-Ibuprofen business to diversify its product range and drive future revenue growth.

Facing higher fuel costs due to the Punjab floods, IOLCP managed to sustain its profitability by focusing on operational efficiency and strategic capex toward automation.